CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,408,000 | 9,826,000 | 7,119,000 | 5,598,000 | 7,854,000 |
| Marketable Securities | 3,117,000 | 3,015,000 | 3,006,000 | 3,190,000 | 3,000,000 |
| Receivables | 24,431,000 | 25,283,000 | 24,164,000 | 23,855,000 | 21,742,000 |
| Inventories | 17,760,000 | 17,399,000 | 16,979,000 | 17,618,000 | 18,496,000 |
| Other current assets | 5,292,000 | 5,319,000 | 5,291,000 | 5,458,000 | 5,277,000 |
| TOTAL | $60,008,000 | $60,842,000 | $56,559,000 | $55,719,000 | $56,369,000 |
| Non-Current Assets | |||||
| PPE Net | 12,896,000 | 12,771,000 | 12,664,000 | 12,611,000 | 12,606,000 |
| Investments And Advances | 23,025,000 | 22,370,000 | 22,136,000 | 21,025,000 | 20,812,000 |
| Intangibles | 108,147,000 | 108,666,000 | 109,632,000 | 110,191,000 | 110,694,000 |
| Other Non-Current Assets | 28,923,000 | 30,242,000 | 30,173,000 | 30,060,000 | 30,234,000 |
| TOTAL | $172,991,000 | $174,049,000 | $174,605,000 | $173,887,000 | $174,346,000 |
| Total Assets | $232,999,000 | $234,891,000 | $231,164,000 | $229,606,000 | $230,715,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,205,000 | 1,561,000 | 60,000 | 2,674,000 | 5,440,000 |
| Accounts payable and accrued liabilities | 38,682,000 | 39,468,000 | 36,691,000 | 35,358,000 | 34,869,000 |
| Accrued Expenses | 17,670,000 | 16,140,000 | 14,827,000 | 14,312,000 | 14,243,000 |
| Other current liabilities | 5,604,000 | 5,731,000 | 5,942,000 | 5,974,000 | 5,827,000 |
| TOTAL | $67,807,000 | $64,709,000 | $59,311,000 | $60,104,000 | $62,017,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,971,000 | 56,832,000 | 59,294,000 | 59,270,000 | 59,207,000 |
| Other Non-Current Liabilities | 31,580,000 | 32,414,000 | 32,429,000 | 32,457,000 | 32,994,000 |
| TOTAL | $89,811,000 | $95,564,000 | $98,288,000 | $98,338,000 | $98,997,000 |
| Total Liabilities | $157,618,000 | $160,273,000 | $157,599,000 | $158,442,000 | $161,014,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,312,510 | 1,320,059 | 1,319,575 | 1,316,568 | 1,311,355 |
| Common Shares | 47,377,000 | 47,133,000 | 46,995,000 | 46,727,000 | 46,513,000 |
| Retained earnings | 54,906,000 | 54,264,000 | 53,331,000 | 51,203,000 | 49,640,000 |
| Other shareholders' equity | 1,271,000 | 1,387,000 | 1,491,000 | 1,336,000 | 1,726,000 |
| TOTAL | $75,381,000 | $74,618,000 | $73,565,000 | $71,164,000 | $69,701,000 |
| Total Liabilities And Equity | $232,999,000 | $234,891,000 | $231,164,000 | $229,606,000 | $230,715,000 |